ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 269 out of 1000

$424K Total Retail Price of All Prescriptions

Rank: 321 out of 1000

342 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 342 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 8,370 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 407 349 1 4
SIMVASTATIN 400 332 2 3
AMLODIPINE BESYLATE 353 294 3 6
OMEPRAZOLE 350 315 4 2
METOPROLOL TARTRATE 315 288 5 19
FUROSEMIDE 295 276 6 7
LOSARTAN POTASSIUM 277 226 7 25
LISINOPRIL 255 186 8 5
LOVASTATIN 248 231 9 41
METFORMIN HCL 245 208 10 8
PRAVASTATIN SODIUM 203 169 11 12
METOPROLOL SUCCINATE 197 189 12 21
HYDROCODONE-ACETAMINOPHEN 196 177 S3 13 1
WARFARIN SODIUM 170 147 14 22
METFORMIN HCL ER 157 134 15 44
ATORVASTATIN CALCIUM 148 129 16 18
EVISTA 140 121 17 168
SERTRALINE HCL 139 92 18 26
HYDROCHLOROTHIAZIDE 135 108 19 9
POTASSIUM CHLORIDE 134 111 20 10
PAROXETINE HCL 129 79 21 63
ENALAPRIL MALEATE 123 107 22 58
CITALOPRAM HBR 117 113 23 17
ATENOLOL 114 71 24 24
PLAVIX 113 101 25 49
ALLOPURINOL 103 88 26 31
CARVEDILOL 97 95 27 15
RAMIPRIL 91 87 28 77
TRIAMTERENE-HCTZ 89 89 29 48
CLOPIDOGREL 89 70 29 35
DONEPEZIL HCL 88 88 31 32
NEXIUM 86 82 32 23
JANUVIA 85 74 33 85
FENOFIBRATE 81 77 34 55
GABAPENTIN 79 58 35 11
BENAZEPRIL HCL 71 68 36 61
LIPITOR 70 64 37 170
LOSARTAN-HYDROCHLOROTHIAZIDE 70 56 37 38
ISOSORBIDE MONONITRATE ER 69 62 39 71
ZETIA 67 52 40 95
GLYBURIDE 64 64 R 41 92
ROPINIROLE HCL 63 54 42 82
CRESTOR 62 52 43 30
COLCRYS 62 50 43 171
ALENDRONATE SODIUM 59 55 45 57
AMLODIPINE BESYLATE-BENAZEPRIL 58 51 46 59
FELODIPINE ER 58 58 46 210
TAMSULOSIN HCL 57 56 48 33
PANTOPRAZOLE SODIUM 56 38 49 28
GLIMEPIRIDE 54 27 50 34
OXYBUTYNIN CHLORIDE 53 30 51 145
CARBIDOPA-LEVODOPA 53 53 51 116
CLONIDINE HCL 52 51 53 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.